Shares of Woodcliff Lake-based specialty pharmaceutical company Eagle Pharmaceuticals Inc. soared 22 percent Wednesday following the news the Centers for Medicare & Medicaid Services (CMS) has established a specific reimbursement code for the company's BENDEKA (bendamustine hydrochloride) treatment for a form of cancer.